Detailed information for compound 802649

Basic information

Technical information
  • TDR Targets ID: 802649
  • Name: (2E)-2-[(4-methoxyphenyl)methylidene]-6-[(4-m ethylphenyl)methyl]-[1,3]thiazolo[3,2-b][1,2, 4]triazine-3,7-dione
  • MW: 395.475 | Formula: C21H21N3O3S
  • H donors: 0 H acceptors: 2 LogP: 4.09 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)/C=C\1/SC2N(C1=O)NC(C(=O)N2)Cc1ccc(cc1)C
  • InChi: 1S/C21H17N3O3S/c1-13-3-5-14(6-4-13)11-17-19(25)22-21-24(23-17)20(26)18(28-21)12-15-7-9-16(27-2)10-8-15/h3-10,12H,11H2,1-2H3/b18-12+
  • InChiKey: ACFYOKUFLTXRSD-LDADJPATSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (2E)-2-[(4-methoxyphenyl)methylene]-6-[(4-methylphenyl)methyl]thiazolo[3,2-b][1,2,4]triazine-3,7-dione
  • (2E)-2-(4-methoxybenzylidene)-6-(4-methylbenzyl)thiazolo[3,2-b][1,2,4]triazine-3,7-quinone

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii bifunctional dihydrofolate reductase-thymidylate synthase 0.0212 0.6121 0.5
Echinococcus multilocularis geminin 0.0173 0.3916 0.6473
Mycobacterium ulcerans glutaminase 0.028 1 1
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase 0.0212 0.6121 0.5
Mycobacterium leprae DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) 0.0211 0.605 1
Brugia malayi Pre-SET motif family protein 0.0213 0.618 0.618
Schistosoma mansoni dihydrofolate reductase 0.0211 0.605 0.605
Echinococcus granulosus dihydrofolate reductase 0.0211 0.605 1
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase 0.0212 0.6121 0.5
Schistosoma mansoni hypothetical protein 0.0173 0.3916 0.3916
Plasmodium vivax bifunctional dihydrofolate reductase-thymidylate synthase, putative 0.0212 0.6121 0.5
Mycobacterium tuberculosis Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) 0.0211 0.605 1
Chlamydia trachomatis dihydrofolate reductase 0.0211 0.605 0.5
Onchocerca volvulus 0.0242 0.7864 1
Trichomonas vaginalis glutaminase, putative 0.028 1 1
Mycobacterium ulcerans dihydrofolate reductase DfrA 0.0211 0.605 0.605
Schistosoma mansoni glutaminase 0.028 1 1
Loa Loa (eye worm) dihydrofolate reductase 0.0211 0.605 0.605
Brugia malayi glutaminase DH11.1 0.028 1 1
Schistosoma mansoni hypothetical protein 0.0173 0.3916 0.3916
Loa Loa (eye worm) pre-SET domain-containing protein family protein 0.0213 0.618 0.618
Leishmania major dihydrofolate reductase-thymidylate synthase 0.0212 0.6121 0.5
Brugia malayi Dihydrofolate reductase 0.0211 0.605 0.605
Trypanosoma brucei dihydrofolate reductase-thymidylate synthase 0.0212 0.6121 0.5
Echinococcus granulosus geminin 0.0173 0.3916 0.6473
Loa Loa (eye worm) glutaminase 0.028 1 1
Brugia malayi dihydrofolate reductase family protein 0.0211 0.605 0.605
Echinococcus multilocularis dihydrofolate reductase 0.0211 0.605 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.